HR
Howard W Robin
President & CEO

Howard W Robin insider trades: Nektar Therapeutics (NKTR) stock buys and sales

President & CEO, Nektar Therapeutics Last trade Aug 18, 2026 102 Form 4 filings
$1.4M
Sold, last 12 months
5 sales
$0
Bought, last 12 months
0 buys
73
Open-market trades
since 2007
2
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Howard reports to the SEC

Open-market buys and sales

73 trades reported on SEC Form 4, newest first

DateStockTypeValue
Aug 18, 2026NKTR↓ Sell$30K
Jun 17, 2026NKTR↓ Sell$1.2M
May 19, 2026NKTR↓ Sell$29K
Feb 18, 2026NKTR↓ Sell$31K
Nov 25, 2025NKTR↓ Sell$120K
Sep 9, 2025NKTR↓ Sell$311K
Sep 5, 2025NKTR↓ Sell$431K
Sep 2, 2025NKTR↓ Sell$45K
Aug 19, 2025NKTR↓ Sell$42K
May 19, 2025NKTR↓ Sell$16K
Feb 19, 2025NKTR↓ Sell$24K
Dec 18, 2024NKTR↓ Sell$132K
Nov 19, 2024NKTR↓ Sell$16K
Aug 19, 2024NKTR↓ Sell$19K
May 17, 2024NKTR↓ Sell$29K
Feb 20, 2024NKTR↓ Sell$14K
Nov 17, 2023NKTR↓ Sell$10K
Aug 16, 2023NKTR↓ Sell$16K
May 16, 2023NKTR↓ Sell$15K
Feb 16, 2023NKTR↓ Sell$59K
Nov 16, 2022NKTR↓ Sell$136K
Aug 16, 2022NKTR↓ Sell$65K
May 16, 2022NKTR↓ Sell$144K
Feb 16, 2022NKTR↓ Sell$137K
Nov 16, 2021NKTR↓ Sell$563K
Aug 16, 2021NKTR↓ Sell$159K
May 17, 2021NKTR↓ Sell$212K
Feb 16, 2021NKTR↓ Sell$257K
Feb 4, 2021NKTR↓ Sell$9.0M
Nov 16, 2020NKTR↓ Sell$203K
Aug 17, 2020NKTR↓ Sell$234K
May 18, 2020NKTR↓ Sell$202K
Feb 18, 2020NKTR↓ Sell$189K
Nov 18, 2019NKTR↓ Sell$244K
Oct 17, 2019NKTR↓ Sell$1.7M
Aug 16, 2019NKTR↓ Sell$228K
Jul 25, 2019NKTR↓ Sell$3.1M
May 23, 2019NKTR↓ Sell$3.3M
May 16, 2019NKTR↓ Sell$420K
Feb 21, 2019NKTR↓ Sell$4.6M
Nov 16, 2018NKTR↓ Sell$586K
Jun 27, 2018NKTR↓ Sell$6.4M
May 16, 2018NKTR↓ Sell$1.1M
May 3, 2018NKTR↓ Sell$10.9M
Feb 16, 2018NKTR↓ Sell$1.1M
Jan 22, 2018NKTR↓ Sell$6.3M
Dec 13, 2017NKTR↓ Sell$4.6M
Nov 1, 2017NKTR↓ Sell$2.0M
Oct 9, 2017NKTR↓ Sell$2.0M
Sep 6, 2017NKTR↓ Sell$1.8M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other NKTR insiders

Open-market trades in the last 12 months

About Howard W Robin's insider trades

Howard W Robin is President & CEO at Nektar Therapeutics (NKTR). Since Mar 5, 2007, Howard has reported 1 open-market purchase worth $113K and 72 sales worth $99.3M on SEC Form 4. In the last 12 months: 5 sales ($1.4M).

Their filings also include option exercises (33 filings), grants and awards (31 filings), shares returned to the company (6 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NKTR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.